stockrow
Friday 6 November 2026
Export OMDA’s income statement to Excel — free account
Omada Health, Inc.
OMDA Healthcare Health Information Services
Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024.
- Revenue
- +34.2%
- EPS
- +283.3%
- Free cash flow
- +45.7%
Quarter to September 2026, against a year earlier
15.10
3.85
−20.32%
Follow OMDA
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Sep ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 123 | 170 | 260 | 333 | +45.6% | 339 | 408 | 492 | +23.7% | |
| Gross margin, % | — | — | — | — | — | — | — | 56.99 | 60.59 | 65.69 | 70.69 | +8.7 pt | ||||||
| EBT | — | — | — | — | — | — | — | (68) | (47) | (13) | 14 | (56.5%) | ||||||
| EBT margin, % | — | — | — | — | — | — | — | (54.98) | (27.76) | (4.91) | 4.21 | +50.1 pt | ||||||
| Net income | — | — | — | — | — | — | — | (68) | (47) | (13) | 14 | (56.5%) | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | 17.32 | 21.99 | 7.10 | 5.42 | (36.0%) | |||||
| Earnings | — | — | — | — | — | — | — | (9.52) | (6.10) | (0.35) | 0.24 | (80.8%) | ||||||
| Cash flow | — | — | — | — | — | — | — | (7.01) | (4.43) | 0.50 | 0.47 | n/m | ||||||
| Capex | — | — | — | — | — | — | — | (0.41) | (0.50) | (0.16) | (0.10) | (37.8%) | ||||||
| Free cash flow | — | — | — | — | — | — | — | (7.43) | (4.93) | 0.34 | 0.37 | n/m | ||||||
| Book value | — | — | — | — | — | — | — | 0.00 | (49.79) | 6.27 | 4.44 | n/m | ||||||
| Shares, m | — | — | — | — | — | — | — | 7 | 8 | 37 | 54 | +127.3% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 62.92 | 0.0 | |||||
| P/S | — | — | — | — | — | — | — | 0.00 | 0.00 | 2.22 | 2.79 | 0.7 | ||||||
| P/B | — | — | — | — | — | — | — | 0.00 | 0.00 | 2.52 | 3.40 | 0.8 | ||||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 0.00 | 1.48 | 2.15 | 0.5 | ||||||
| EV/FCF | — | — | — | — | — | — | — | (2.58) | (2.58) | 31.09 | 31.81 | 8.6 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | (50) | (34) | 18 | 29 | n/m | |||||
| Capex | — | — | — | — | — | — | — | (3) | (4) | (6) | (6) | +41.3% | ||||||
| Free cash flow | — | — | — | — | — | — | — | (53) | (38) | 12 | 22 | n/m | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | 59 | 197 | 240 | +233.7% | |||||
| Net debt | — | — | — | — | — | — | — | — | (47) | (222) | (243) | +376.3% | ||||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | (384) | 230 | 273 | n/m | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | 0.00 | (62.48) | (5.60) | 4.41 | (5.6) pt | |||||
| ROIC | — | — | — | — | — | — | — | 0.00 | 0.00 | (97.89) | 14.34 | (97.9) pt | ||||||
| ROE | — | — | — | — | — | — | — | 0.00 | 0.00 | 16.52 | 5.72 | +16.5 pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | — | 916 | — | — | |||||
| Revenue/emp, $m | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.28 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 6 Nov 2026
Omada Health, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| SDGR Schrodinger, Inc. | $2.2B | — (loss-making) | — (loss-making) | +18.72% (above 0%: growing) | n/m | +21.64% (above 0%: growing) | 59.32% | (40.52%) | Compare |
| CERT Certara, Inc. | $1.9B | — (loss-making) | — (loss-making) | −9.29% (below 0%: shrinking) | +300.00% (above 0%: growing) | −12.09% (below 0%: shrinking) | 66.87% | 2.45% | Compare |
| OMCL Omnicell, Inc. | $1.7B | 39.0× | 32.9× | −0.89% (below 0%: shrinking) | +100.50% (above 0%: growing) | +42.62% (above 0%: growing) | 44.77% | 4.85% | Compare |
| TDOC Teladoc Health, Inc. | $1.7B | — (loss-making) | — (loss-making) | −3.41% (below 0%: shrinking) | n/m | +11.76% (above 0%: growing) | 68.56% | (4.64%) | Compare |
| GDRX GoodRx Holdings, Inc. | $1.2B | 65.7× | 46.0× | −1.31% (below 0%: shrinking) | −25.00% (below 0%: shrinking) | +112.45% (above 0%: growing) | 89.52% | 11.79% | Compare |
| OMDA Omada Health, Inc. | $1.2B | 267× | 156× | +43.12% (above 0%: growing) | n/m | +45.71% (above 0%: growing) | 72.62% | 4.04% | |
| HSTM HealthStream, Inc. | $905.6M | 42.0× | 45.4× | +8.94% (above 0%: growing) | −8.90% (below 0%: shrinking) | −4.80% (below 0%: shrinking) | 63.98% | 7.91% | Compare |
| PHR Phreesia, Inc. | $788.9M | 74.4× | 40.2× | +10.41% (above 0%: growing) | +200.00% (above 0%: growing) | +43.51% (above 0%: growing) | 66.64% | 5.88% | Compare |
| NRC National Research Corporation | $563.6M | 87.6× | 61.1× | +10.95% (above 0%: growing) | +22.22% (above 0%: growing) | −31.38% (below 0%: shrinking) | 59.95% | 23.20% | Compare |
| Median of peers | $1.5B | 65.7× | 45.4× | +4.02% | +61.36% | +16.70% | 65.31% | 5.37% |
Pay and ownership Proxy statement filed 28 April 2026
Ownership
Directors and executive officers, together
6.38%
Entities Affiliated with Revelation Partners
8.77%
Entities affiliated with Divisadero Street Capital Management, LP
8.51%
FMR LLC
8.27%
Entities affiliated with Andreessen Horowitz
6.09%
Cigna Ventures, LLC
5.80%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement